Quantifying Robustness to Unmeasured Confounding in Time-Varying Treatment Confounder Settings: An Extension of E-value Approach
Md. Niamul Islam Sium

TL;DR
This paper extends the E-value method to assess robustness against unmeasured confounding in longitudinal studies with time-varying treatments, revealing greater vulnerability than single time-point analyses suggest.
Contribution
It introduces a new bias factor for multiple time points and provides practical tools for sensitivity analysis in complex longitudinal settings.
Findings
Unmeasured confounders with 1.96-fold associations can nullify effects in simulations.
Time-varying E-values are lower than single time-point E-values, indicating higher vulnerability.
Re-analysis shows similar patterns, confirming the method's applicability.
Abstract
Background: The E-value has become widely used for assessing robustness to unmeasured confounding in observational studies, but the original framework was developed for single time-point exposure-outcome settings. This study extends the E-value methodology to longitudinal set up with time-varying treatments and confounders, where treatment-confounder feedback occurs. Methods: A combined bias factor accounting for unmeasured confounding at multiple time points was extended, with three reporting scenarios presented: equal bias distribution across time points, confounding at a single time point, and a general case visualizing all possible confounder strength combinations. Results: In simulations with an observed risk ratio of 1.73, unmeasured confounders with 1.96-fold associations at each time point could nullify the effect under equal distribution-substantially lower than the single…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdvanced Causal Inference Techniques · Health Systems, Economic Evaluations, Quality of Life · Statistical Methods in Clinical Trials
